Abstract
Background: Focal liver lesions have a broad differential diagnosis. MRI with its improved soft tissue characterization and newer sequences can significantly narrow the differentials especially when discriminating benign from malignant lesions. Methods: T1, T1 IN AND OUT OF PHASE, T2, LONG TE T2 AND Diffusion Weighted Imaging was done in 159 patients with USG documented focal liver lesion. Qualitative and quantitative assessment of ADC values and long TE images was done and a threshold for differentiating benign from malignant lesions was obtained. The MRI diagnosis was compared with final diagnosis obtained from histopathology in most cases or follow up and other tests (markers and RBC scan) were histopathology was not available. Sensitivity, specificity and accuracy of MRI sequences in differentiating various focal lesions were obtained. Results: T1 weighted images were useful for identifying fat, hemorrhage and iron within the lesions. T2 weighted imaging was able to correctly classify 82.0% lesions as malignant and 83.7% lesions as benign. Long TE T2 images were highly accurate in distinguishing haemangiomas and cysts from solid lesions. On diffusion-weighted (DW) imaging, 89.5% (i.e. 60 out of 67) lesions were correctly classified as malignant and 88.0% (i.e. 81 out of 92) lesions were correctly classified as benign. Threshold ADC value of 1.37 × 10-3 mm2/s is highly accurate for differentiating malignant from benign lesions. Conclusion: DWI is a sine qua non in liver lesion assessment allowing improved detection and characterization. Long TE T2 weighted imaging can accurately detect haemangiomas and cysts and rule out metastasis.
Highlights
Focal liver lesions have broad differential diagnoses
Our study aimed to evaluate the role of various magnetic resonance imaging (MRI) sequences in discriminating various focal liver lesions and build a comprehensive protocol for assessing these lesions using MRI
The final diagnosis was confirmed by histopathology/ cytology (n=107)
Summary
Focal liver lesions have broad differential diagnoses. With its improved soft tissue characterization and newer sequences, magnetic resonance imaging (MRI) can significantly narrow the differential diagnoses, especially when discriminating benign from malignant lesions. Imaging modalities currently available to evaluate focal liver disease include trans-abdominal and intra-operative ultrasound, triphasic computed tomography (CT), computed tomographic arterial portography (CTAP), and magnetic resonance imaging (MRI) enhanced with one or more types of contrast agent. These are often complementary, and various combinations may be appropriate in different clinical settings. For focal liver lesion detection and characterization, MRI relies on T1-weighted, T2-weighted, diffusion-weighted
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.